Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
MedAdvisor Limited ( (AU:MDR) ) has shared an update.
Jencay Capital Pty Limited, a substantial holder in MedAdvisor Limited, has increased its voting power from 7.24% to 8.39% by purchasing an additional 9,142,870 ordinary shares. This change in shareholding indicates a growing interest and confidence in MedAdvisor’s operations, potentially impacting the company’s market positioning and signaling positive implications for stakeholders.
The most recent analyst rating on (AU:MDR) stock is a Hold with a A$0.21 price target. To see the full list of analyst forecasts on MedAdvisor Limited stock, see the AU:MDR Stock Forecast page.
More about MedAdvisor Limited
MedAdvisor Limited operates in the healthcare technology industry, focusing on providing digital medication management solutions. The company aims to improve patient health outcomes by offering services that help users manage their medications effectively.
Average Trading Volume: 994,248
Technical Sentiment Signal: Sell
Current Market Cap: A$30.61M
Learn more about MDR stock on TipRanks’ Stock Analysis page.